All articles by Tori Rodriguez, MA, LPC
Researchers found data that showed, regardless of the number of headaches reported in addition to insomnia that cognitive behavioral therapy is indicated as first-line treatment.
Detecting CTE in the brains of living individuals could improve our understanding of the disease and inform research regarding prevention and treatment.
Accurate diagnosis is essential to inform treatment strategy, particularly with headaches that may be secondary to a potentially life-threatening medical condition.
Considering individual patient factors, effects of aging, and using online tools for drug interactions will aid in treatment of migraines in the elderly.
Based on the literature, investigators found no reason to tell patients with headache to abstain from alcohol.
Cognitive reserve may attenuate the impact of MS on cognitive function in some patients.
Sleep alterations often precede cognitive and motor symptoms in PD and appear during the prodromal phase of the disease.
Depression is the most frequently observed psychiatric disorder in HD, with an estimated prevalence of 40% to 50%.
There is significant evidence that opioids are not the right treatment of choice for migraine in the emergency department.
The results highlight the importance of evaluating and monitoring cognitive function in individuals with recent critical illness or major infections, especially if they are already at risk for dementia.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
There are considerations for treating these seizures as part of the overall goals of palliative care, which include the family’s experience.
Future studies on VR training for MS should include large randomized controlled trials using clear protocols and comparable between-group tasks.
Companies touting these therapies may use impressive websites with endorsements by celebrities and physicians to instill a sense that the procedures are safe and acceptable.
Data in children do support an association between pediatric obesity and headache disorders in general, but more research is needed to confirm the association specifically with pediatric migraine.
While it is now well-established that having MS should not limit patients’ reproductive choices, this was not always the case.
Direct-to-consumer genetic testing would enable consumers to bypass the safeguards set forth by professional guidelines, which could potentially increase the risk for harm associated with testing.
Cognitive and linguistic deficits have been cited as risk factors for psychiatric comorbidity in pediatric epilepsy, along with family factors such as parenting style and quality of the parent-child relationship.
Cannabis has been shown to reduce the use of prescription drugs that have more numerous and serious side effects, including opioids, benzodiazepines, and antidepressants.
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
In April 2018, the American Academy of Neurology released updated guidelines for the treatment of multiple sclerosis (MS). The new recommendations are based on a panel review of 20 Cochrane reviews and 73 full-text articles pertaining to starting, switching, and stopping disease-modifying treatment in patients with clinically isolated syndrome, relapsing-remitting MS, and progressive forms of MS.
Each component of NEDA has limitations — for example, measures of brain atrophy may be confounded by various factors, and the correlation between short-term measures of EDSS progression and long-term disability outcomes is unclear.
While immunocompromised patients are the most susceptible to CNS fungal infections, they can also occur in immunocompetent patients undergoing invasive procedures such as neurosurgery and in patients exposed to contaminated devices or drugs.
Neurology Advisor speaks with Annabelle Baughan, a retired hematologist-oncologist, and discusses her personal experience with Andersen-Tawil syndrome.
As the most effective treatment for a patient with multiple sclerosis is one that is specifically tailored to the patient’s individual needs and preferences, recognition of the unique characteristics, preferences, and trends shared by the millennial generation should drive innovative solutions.
Neurology Advisor spoke with Annabelle Baughan, a retired hematologist-oncologist, who discussed her personal experience with Andersen-Tawil syndrome.
Before we begin to rely more heavily on technology for seizure detection, clinician-patient trust needs to improve.